Testing effectiveness (Phase 2)Study completedNCT03020745
What this trial is testing
Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3389404 in Chronic Hepatitis B (CHB) Subjects
Who this might be right for
Hepatitis B
GlaxoSmithKline 78